SBC Medical Group (SBC)
SBC Medical Statistics
Share Statistics
SBC Medical has 103.61M shares outstanding. The number of shares has increased by null% in one year.
| Shares Outstanding | 103.61M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | n/a |
| Owned by Institutions (%) | n/a |
| Shares Floating | - |
| Failed to Deliver (FTD) Shares | 1.8K |
| FTD / Avg. Volume | 5.72% |
Short Selling Information
| Short Interest | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Valuation Ratios
The PE ratio is 11.52 and the forward PE ratio is 6.19. SBC Medical's PEG ratio is 0.5.
| PE Ratio | 11.52 |
| Forward PE | 6.19 |
| PS Ratio | 2.61 |
| Forward PS | 1.5 |
| PB Ratio | 2.75 |
| P/FCF Ratio | 31.26 |
| PEG Ratio | 0.5 |
Enterprise Valuation
SBC Medical has an Enterprise Value (EV) of 424.05M.
| EV / Sales | 2.06 |
| EV / EBITDA | 4.76 |
| EV / EBIT | 20.6 |
| EV / FCF | 24.69 |
Financial Position
The company has a current ratio of 3.01, with a Debt / Equity ratio of 0.06.
| Current Ratio | 3.01 |
| Quick Ratio | 2.99 |
| Debt / Equity | 0.06 |
| Debt / EBITDA | 0.14 |
| Debt / FCF | 0.71 |
| Interest Coverage | 2484.23 |
Financial Efficiency
Return on Equity is 23.89% and Return on Invested Capital is 21.34%.
| Return on Equity | 23.89% |
| Return on Assets | 17.52% |
| Return on Invested Capital | 21.34% |
| Revenue Per Employee | $238.02K |
| Profits Per Employee | $54.01K |
| Employee Count | 863 |
| Asset Turnover | 0.77 |
| Inventory Turnover | 33.02 |
Taxes
| Income Tax | 26.77M |
| Effective Tax Rate | 36.44% |
Stock Price Statistics
The stock price has increased by -74.46% in the last 52 weeks. The beta is 0.85, so SBC Medical's price volatility has been higher than the market average.
| Beta | 0.85 |
| 52-Week Price Change | -74.46% |
| 50-Day Moving Average | 3.94 |
| 200-Day Moving Average | 7.34 |
| Relative Strength Index (RSI) | 47.68 |
| Average Volume (20 Days) | 31.48K |
Income Statement
In the last 12 months, SBC Medical had revenue of 205.42M and earned 46.61M in profits. Earnings per share was 0.48.
| Revenue | 205.42M |
| Gross Profit | 156.05M |
| Operating Income | 70.3M |
| Net Income | 46.61M |
| EBITDA | 89.16M |
| EBIT | 85.36M |
| Earnings Per Share (EPS) | 0.48 |
Balance Sheet
The company has 125.04M in cash and 12.21M in debt, giving a net cash position of 112.83M.
| Cash & Cash Equivalents | 125.04M |
| Total Debt | 12.21M |
| Net Cash | 112.83M |
| Retained Earnings | 189.46M |
| Total Assets | 266.08M |
| Working Capital | 123.26M |
Cash Flow
In the last 12 months, operating cash flow was 20.58M and capital expenditures -3.41M, giving a free cash flow of 17.17M.
| Operating Cash Flow | 20.58M |
| Capital Expenditures | -3.41M |
| Free Cash Flow | 17.17M |
| FCF Per Share | 0.18 |
Margins
Gross margin is 75.97%, with operating and profit margins of 34.23% and 22.69%.
| Gross Margin | 75.97% |
| Operating Margin | 34.23% |
| Pretax Margin | 35.76% |
| Profit Margin | 22.69% |
| EBITDA Margin | 43.41% |
| EBIT Margin | 34.23% |
| FCF Margin | 8.36% |
Dividends & Yields
SBC does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Payout Ratio | n/a |
| Earnings Yield | 8.68% |
| FCF Yield | 3.2% |
Analyst Forecast
Currently there are no analyst rating for SBC.
| Price Target | n/a |
| Price Target Difference | n/a |
| Analyst Consensus | n/a |
| Analyst Count | n/a |
Scores
| Altman Z-Score | 6.28 |
| Piotroski F-Score | 7 |